Early and sustained LDL-C goal achieved with inclisiran in patients at high cardiovascular risk
More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when given on top of individually ...
Sep 1, 2025
0
13









